2022.01.29
on-treatment blood tmb as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase iii trial
注：图片来源于molecular cancer
返 回
germline hla-b evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer